Jeffrey D. Hermes

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

6

H-Index

1

About

Jeffrey D. Hermes is a leading figure in the development of automated platforms for high-throughput drug discovery, with a particular focus on assay miniaturization and precision pharmacology. His most cited work, "Development of a Platform to Enable Fully Automated Cross-Titration Experiments" (2016, 6 citations), addresses a critical bottleneck in lead optimization: the labor-intensive process of testing compounds at multiple concentrations to determine potency and maximal effect. By designing a fully automated system for cross-titration experiments, Hermes enabled researchers to conduct complex follow-up assays—such as agonist shift studies—with unprecedented efficiency and reproducibility. This contribution has streamlined the triage of hits from high-throughput screening campaigns and accelerated the optimization of lead compounds. While his citation count reflects the specialized nature of his work, its impact is deeply felt in pharmaceutical R&D, where automation and precision are paramount. Hermes’ platform represents a significant advancement in reducing manual error and increasing throughput, making him a key innovator in the field of automated assay development.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Development of a Platform to Enable Fully Automated Cross-Titration Experiments
6 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago